organophosphonates has been researched along with Cytomegaloviral Retinitis in 113 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 77 (68.14) | 18.2507 |
2000's | 30 (26.55) | 29.6817 |
2010's | 6 (5.31) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Asano-Mori, Y; Chiba, S; Kako, S; Kanda, Y; Kurokawa, M; Motokura, T; Oshima, K; Shiraki, K; Watanabe, T | 1 |
Beadle, JR; Cheng, L; Freeman, WR; Hoh, C; Hostetler, KY; Tammewar, A | 1 |
Bazewicz, M; Caspers, L; Fikri, J; Frippiat, F; Libois, A; Martin, CH; Meunier, A; Willermain, F | 1 |
Aldern, KA; Beadle, JR; Cheng, L; Chhablani, J; Conner, L; Freeman, WR; Hartmann, K; Hostetler, KY; Pearson, L; Wang, H | 1 |
Chavala, S; Miller, MB; Moss, HB; Say, E | 1 |
Bagui, M; Barot, M; Gokulgandhi, MR; Mitra, AK; Pal, D | 1 |
Ang, BC; Teoh, SC | 1 |
Chialant, D; Damji, KF; Hodge, WG; Wang, L | 1 |
Duncan, BA; Ingrosso, A; Mucci, M; Nickens, DJ; Rodríguez, CA; Wolf, DL | 1 |
Gerding, H; Hackethal, U; Holzapfel, C; Husstedt, IW | 1 |
Bolger, GT; Bousquet, C; Cordingley, MG; Garneau, M; Kibler, P; Tremblay, F | 1 |
Chiambaretta, F; Jacomet, C; Ménérath, JM; Pilon, F; Rapp, P | 1 |
Azen, SP; Buley, A; Chaidhawangul, S; Cheng, L; Freeman, WR; Ozerdem, U; Scholz, B; Song, MK; Torriani, F | 1 |
Dunn, JP; Foster, G; Jabs, DA; Kuppermann, BD; Martin, DF; Van Natta, M; Zong, A | 1 |
Bidanset, DJ; Hartline, CB; Kern, ER; Rybak, RJ | 1 |
Meyerle, JH; Turiansky, GW | 1 |
Barat, A; Caramelo, C; Egido, J; Guerrero, MF; Justo, P; Melero, R; Müller, G; Ortiz, A; Sanz, A; Strutz, F | 1 |
Beadle, JR; Cheng, L; Davidson, MC; Freeman, WR; Hostetler, KY; Koh, HJ; Lu, S | 1 |
Dieterich, DT; Freeman, WR; Friedberg, DN; Holland, GN; Jabs, DA; Kempen, JH; Min, YI | 1 |
Nightingale, SL | 1 |
Arevalo, JF; Chavez de la Paz, E; De Clercq, E; Freeman, WR; Garcia, R; Kirsch, LS; Munguia, D | 1 |
Cohen, J | 1 |
Masur, H; Polis, MA | 1 |
Arevalo, JF; Chavez de la Paz, E; de Clercq, E; Freeman, WR; Kirsch, LS; Munguia, D | 1 |
Cundy, KC; Hitchcock, MJ; Lee, WA; Lynch, G; Shaw, JP | 1 |
Arevalo, JF; Azen, SP; Chavez de la Paz, E; Freeman, WR; Munguia, D; Rahhal, FM; Taskintuna, I | 1 |
Freeman, WR | 1 |
Flaherty, JF | 1 |
Bryson, HM; Lea, AP | 1 |
Schwartz, DM | 1 |
Drew, WL; Holland, GN; Ives, DV; Jaffe, HS; Kramer, F; Kuppermann, BD; Lalezari, JP; Robinson, MR; Stagg, RJ; Youle, M | 1 |
Hardy, WD | 1 |
Kuppermann, BD | 1 |
Lalezari, JP | 1 |
Kuppermann, BD; Lalezari, JP | 1 |
Arevalo, JF; Chavez-de la Paz, E; De Clercq, E; Freeman, WR; Kirsch, LS; Munguia, D; Rahhal, FM | 1 |
Arevalo, JF; Banker, AS; De Clercq, E; Freeman, WR; Munguia, D; Rahhal, FM; Taskintuna, I | 1 |
Jacobson, MA | 1 |
Gazzard, BG; Morris-Jones, S; Nelson, M; Sadler, M | 1 |
Beaufils, H; Deray, G; Dumitrescu, L; Vittecoq, D | 1 |
Rockstroh, JK; Sauerbruch, T; Schliefer, K; Spengler, U | 1 |
Katlama, C | 1 |
Kravcik, S | 1 |
Palau, LA; Pankey, GA; Tufty, GT | 1 |
Vaghjimal, A | 1 |
Arevalo, JF; Banker, AS; De Clercq, E; Freeman, WR; Mueller, AJ; Rahhal, FM; Rao, NA; Taskintuna, I; Wiley, CA | 1 |
Ai, E; Freeman, WR; Mueller, AJ; Powell, HC; Rahhal, FM; Smith, IL; Spector, SA; Taskintuna, I | 1 |
Smith, CL | 1 |
Pau, AK | 1 |
Hardy, WD; Holland, GN; Ives, DV; Jaffe, HS; Johnson, M; Kemper, CA; Kramer, F; Kuppermann, BD; Lalezari, JP; Lewis, RA; McKinley, GF; Nelson, R; Northfelt, DW; Ruby, AE; Simon, GL; Stagg, RJ; Weinberg, DV; Wolitz, RA; Youle, M | 1 |
Akler, ME; Burman, WJ; Johnson, DW; Johnson, SC | 1 |
Behnsch, M; Bergmann, F; Grobusch, MP; Liekfeld, A; Schürmann, D | 1 |
Freeman, WR; Karavellas, MP; Macdonald, JC; Morse, LS; Reed, JB; Torriani, FJ | 1 |
Schleppy, CA; Tritten, JJ | 1 |
Hammoud, Z; Parenti, DM; Simon, GL | 1 |
Dunn, JP; Enger, C; Forman, M; Jabs, DA | 1 |
Dunn, JP; Enger, C; Forman, M; Hubbard, L; Jabs, DA | 1 |
Freeman, WR; Garcia, CR; Torriani, FJ | 1 |
Althaus, C; Hudde, T; Kersten, A; Pascha, G; Schweykart, N; Sundmacher, R | 1 |
Mucci, M | 1 |
Cockerell, CJ; Zabawski, EJ | 1 |
Cherrington, JM; Drew, WL; Fuller, MD; Lalezari, JP; Lamy, PD; Miner, R; Nuessle, S | 1 |
Avila, CP; Cheng, L; Freeman, WR; Keefe, KS; Macdonald, JC; Rao, NA | 1 |
Bolton, SG; Dunn, JP; Jabs, DA; Palestine, AG | 1 |
Azen, SP; Freeman, WR; Karavellas, MP; Macdonald, JC; Plummer, DJ; Shufelt, CL; Torriani, FJ | 1 |
Cazorla, C; Dupon, M; Dutronc, H; Lacut, JY; Neau, D; Ragnaud, JM; Renaud-Rougier, MB; Viallard, JE | 1 |
Engstrom, RE; Holland, GN; Lin, AP | 1 |
Mortimer, CB; Salit, IE; Tseng, AL | 1 |
Cherrington, J; Holtzer, C; Jacobson, MA; Safrin, S; Stanley, H; Wilson, S | 1 |
Skiest, DJ | 1 |
Canzano, JC; Morse, LS; Wendel, RT | 1 |
Noble, S; Plosker, GL | 1 |
Ambati, J; Angerame, MC; Robinson, MR; Wynne, KB | 1 |
Althaus, C; Best, J; Kersten, AJ; Sundmacher, R | 1 |
Hoy, J | 1 |
Cherrington, J; Jaffe, HS; Safrin, S | 1 |
Berenguer, J; Mallolas, J | 1 |
Au Eong, KG; Beatty, S; Charles, SJ | 1 |
Ainsworth, J; Bainbridge, JW; Pinching, AJ; Raina, J; Shah, SM | 1 |
Botsis, C; Kyriakis, KP; Paparizos, VA; Papastamopoulos, V; Stavrianeas, NG; Zagoraios, Y | 1 |
Schmidt, RE; Werwitzke, S; Witte, T | 1 |
Althaus, C; Best, J; Gantke, B; Kersten, A; Theisen, A | 1 |
Hoffman, VF; Skiest, DJ | 1 |
Chou, S; Drew, WL; Miner, RC | 1 |
de Górgolas Hernández-Mora, M; Fernández Guerrero, ML; Nodar, A; Seijas, M | 1 |
Boeckh, M; Chuang, EL; Corey, L; Crippa, F; Sale, G | 1 |
Castillo, A; García Feijoó, J; García Sánchez, J; Martínez de la Casa, JM; Matilla Rodero, M | 1 |
Blanchet, KD | 1 |
Torres, G | 1 |
Cheng, B | 1 |
Feinberg, J | 1 |
Smart, T | 1 |
MacDougall, DS | 1 |
Highleyman, L | 1 |
Bowers, M | 1 |
Cadman, J | 1 |
Korobelnik, JF; Lacut, Y; Le Rebeller, MJ; Neau, D; Ragnaud, JM; Rougier, MB; Viallard, JF | 1 |
Lee, TA; Malinverni, R; Pleil, AM; Ramsey, SD; Steger, PJ; Sullivan, SD; Veenstra, DL; Williamson, T | 1 |
Boulad, F; Cihlar, T; George, D; Kiehn, TE; Lin, DC; Polsky, B; Prasad, VK; Regan, A; Seo, SK | 1 |
Soltau, JB | 1 |
Accorinti, M; Ciapparoni, V; Pirraglia, MP; Pivetti-Pezzi, P | 1 |
Williams, IG | 1 |
Di Perri, G; Maiello, A; Quario, M; Racca, D; Sinicco, A; Zeme, DA | 1 |
22 review(s) available for organophosphonates and Cytomegaloviral Retinitis
Article | Year |
---|---|
[Ocular complications of the virostatic drug cidofovir].
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Eye Diseases; Humans; Infusions, Intravenous; Injections; Leukoencephalopathy, Progressive Multifocal; Ocular Hypotension; Organophosphonates; Organophosphorus Compounds; Uveitis, Anterior; Vitreous Body | 2003 |
Promising new treatments for cytomegalovirus retinitis.
Topics: AIDS-Related Opportunistic Infections; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Drug Implants; Foscarnet; Ganciclovir; Humans; Injections, Intralesional; Organophosphonates; Organophosphorus Compounds | 1995 |
Cidofovir.
Topics: Animals; Antiviral Agents; Cidofovir; Clinical Trials as Topic; Cytomegalovirus; Cytomegalovirus Retinitis; Cytosine; Drug Resistance, Microbial; Humans; Nucleic Acid Synthesis Inhibitors; Organophosphonates; Organophosphorus Compounds | 1996 |
New therapies for cytomegalovirus retinitis.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Drug Administration Routes; Drug Therapy, Combination; Ganciclovir; Humans; Organophosphonates; Organophosphorus Compounds; Treatment Outcome | 1996 |
Management strategies for patients with cytomegalovirus retinitis.
Topics: Administration, Oral; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Drug Implants; Drug Interactions; Drug Therapy, Combination; Foscarnet; Ganciclovir; Humans; Infusions, Intravenous; Organophosphonates; Organophosphorus Compounds | 1997 |
Therapeutic options for resistant cytomegalovirus retinitis.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Retinitis; Cytosine; Drug Implants; Drug Resistance, Microbial; Drug Therapy, Combination; Foscarnet; Ganciclovir; Humans; Infusions, Intravenous; Organophosphonates; Organophosphorus Compounds; Recurrence; Thionucleotides | 1997 |
Cidofovir: a new therapy for cytomegalovirus retinitis.
Topics: AIDS-Related Opportunistic Infections; Animals; Antiviral Agents; Cidofovir; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Cytomegalovirus Retinitis; Cytosine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Kidney; Organophosphonates; Organophosphorus Compounds; Probenecid; Renal Agents | 1997 |
Clinical experience with cidofovir in the treatment of cytomegalovirus retinitis.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Cytomegalovirus Retinitis; Cytosine; Humans; Kidney; Organophosphonates; Organophosphorus Compounds | 1997 |
Treatment of cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome.
Topics: Administration, Oral; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Drug Implants; Drug Therapy, Combination; Foscarnet; Ganciclovir; Humans; Organophosphonates; Organophosphorus Compounds | 1997 |
Management of CMV retinitis in HIV infected patients.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Clinical Trials as Topic; Cytomegalovirus Retinitis; Cytosine; Foscarnet; Ganciclovir; Guanine; Humans; Organophosphonates; Organophosphorus Compounds; Prodrugs; Prospective Studies; Recurrence | 1997 |
Local therapy for cytomegalovirus retinitis.
Topics: Administration, Topical; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Foscarnet; Ganciclovir; Humans; Organophosphonates; Organophosphorus Compounds; Vitreous Body | 1998 |
Cidofovir in the treatment of cytomegalovirus (CMV) retinitis.
Topics: Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Drug Implants; Foscarnet; Ganciclovir; Humans; Injections; Organophosphonates; Organophosphorus Compounds | 1998 |
Topical and intralesional cidofovir: a review of pharmacology and therapeutic effects.
Topics: Administration, Cutaneous; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Herpesviridae Infections; Humans; Injections, Intralesional; Injections, Intravenous; Molluscum Contagiosum; Organophosphonates; Organophosphorus Compounds; Papillomaviridae; Papillomavirus Infections; Sarcoma, Kaposi; Skin Diseases, Viral; Skin Neoplasms; Tumor Virus Infections | 1998 |
Cytomegalovirus retinitis in the era of highly active antiretroviral therapy (HAART).
Topics: Antiviral Agents; Biomarkers; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Diagnosis, Differential; Foscarnet; Ganciclovir; Herpesviridae; Humans; Incidence; Organophosphonates; Organophosphorus Compounds; Risk Factors | 1999 |
Cidofovir: a review of its use in cytomegalovirus retinitis in patients with AIDS.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Clinical Trials as Topic; Cytomegalovirus Retinitis; Cytosine; Humans; In Vitro Techniques; Organophosphonates; Organophosphorus Compounds | 1999 |
Management of CMV infections in HIV-infected patients.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Foscarnet; Ganciclovir; Humans; Organophosphonates; Organophosphorus Compounds | 1999 |
Cidofovir. Review of current and potential clinical uses.
Topics: AIDS-Related Opportunistic Infections; Animals; Antiviral Agents; Cidofovir; Clinical Trials as Topic; Cytomegalovirus; Cytomegalovirus Infections; Cytomegalovirus Retinitis; Cytosine; Humans; Organophosphonates; Organophosphorus Compounds | 1999 |
Cytomegalovirus retinitis in patients with acquired immune deficiency syndrome.
Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Foscarnet; Ganciclovir; HIV Infections; Humans; Organophosphonates; Organophosphorus Compounds; Retinal Detachment | 1999 |
Therapeutic developments in cytomegalovirus retinitis.
Topics: Adenine; Antibodies, Monoclonal; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Drugs, Investigational; Foscarnet; Ganciclovir; Guanine; Humans; Organophosphonates; Organophosphorus Compounds; Thionucleotides; Valganciclovir | 2000 |
[Ocular complications after treatment with intravenous cidofovir for cytomegalovirus retinitis].
Topics: Acute Disease; Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Humans; Injections, Intravenous; Male; Ocular Hypotension; Organophosphonates; Organophosphorus Compounds; Uveitis, Anterior | 2001 |
Economic evaluation of systemic treatments for cytomegalovirus retinitis in patients with AIDS.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Economics, Pharmaceutical; Foscarnet; Ganciclovir; Humans; Models, Economic; Organophosphonates; Organophosphorus Compounds; Switzerland; Treatment Failure | 2001 |
Management of CMV disease in HIV infection.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Infections; Cytomegalovirus Retinitis; Cytosine; Encephalitis, Viral; Foscarnet; Ganciclovir; Gastrointestinal Diseases; Humans; Organophosphonates; Organophosphorus Compounds | 1999 |
13 trial(s) available for organophosphonates and Cytomegaloviral Retinitis
Article | Year |
---|---|
Pharmacokinetics and renal effects of cidofovir with a reduced dose of probenecid in HIV-infected patients with cytomegalovirus retinitis.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Kidney; Male; Middle Aged; Organophosphonates; Organophosphorus Compounds; Probenecid | 2003 |
Complications of ganciclovir implant surgery in patients with cytomegalovirus retinitis: the Ganciclovir Cidofovir Cytomegalovirus Retinitis Trial.
Topics: Administration, Oral; Adult; AIDS-Related Opportunistic Infections; Anesthesia, General; Anesthesia, Local; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Drug Implants; Female; Ganciclovir; Humans; Infusions, Intravenous; Intraoperative Complications; Male; Organophosphonates; Organophosphorus Compounds; Postoperative Complications; Prospective Studies; Visual Acuity; Vitreous Hemorrhage | 2004 |
Phase I/II study of intravitreal cidofovir for the treatment of cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Drug Tolerance; Female; Fundus Oculi; Humans; Injections; Male; Middle Aged; Ocular Hypotension; Organophosphonates; Organophosphorus Compounds; Survival Analysis; Vitreous Body | 1995 |
Intravitreal cidofovir (HPMPC) treatment of cytomegalovirus retinitis in patients with acquired immune deficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Ciliary Body; Cytomegalovirus Retinitis; Cytosine; Drug Therapy, Combination; Female; Humans; Injections; Intraocular Pressure; Male; Middle Aged; Organophosphonates; Organophosphorus Compounds; Probenecid; Retina; Uveitis; Vitreous Body | 1995 |
Intravenous cidofovir for peripheral cytomegalovirus retinitis in patients with AIDS. A randomized, controlled trial.
Topics: Adolescent; Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Disease Progression; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Organophosphonates; Organophosphorus Compounds; Prospective Studies; Visual Acuity | 1997 |
Parenteral cidofovir for cytomegalovirus retinitis in patients with AIDS: the HPMPC peripheral cytomegalovirus retinitis trial. A randomized, controlled trial. Studies of Ocular complications of AIDS Research Group in Collaboration with the AIDS Clinical
Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Combined Modality Therapy; Cytomegalovirus Retinitis; Cytosine; Disease Progression; Drug Administration Schedule; Female; Fluid Therapy; Humans; Kidney Diseases; Male; Organophosphonates; Organophosphorus Compounds; Probenecid; Prospective Studies; Renal Agents; Visual Acuity | 1997 |
Anterior nongranulomatous uveitis after intravitreal HPMPC (cidofovir) for the treatment of cytomegalovirus retinitis. Analysis and prevention.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Glucocorticoids; Granuloma; Humans; Incidence; Injections; Iritis; Mydriatics; Organophosphonates; Organophosphorus Compounds; Probenecid; Prospective Studies; Uricosuric Agents; Vitreous Body | 1997 |
Randomized, controlled study of the safety and efficacy of intravenous cidofovir for the treatment of relapsing cytomegalovirus retinitis in patients with AIDS.
Topics: Adolescent; Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Creatinine; Cytomegalovirus Retinitis; Cytosine; Disease Progression; Drug Therapy, Combination; Female; Humans; Infusions, Intravenous; Intraocular Pressure; Kidney; Male; Middle Aged; Organophosphonates; Organophosphorus Compounds; Probenecid; Proteinuria; Recurrence; Renal Agents; Risk Factors; Visual Acuity | 1998 |
Phase I study of combination therapy with intravenous cidofovir and oral ganciclovir for cytomegalovirus retinitis in patients with AIDS.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Drug Therapy, Combination; Female; Ganciclovir; Humans; Male; Middle Aged; Organophosphonates; Organophosphorus Compounds; Treatment Outcome | 1999 |
Long-term follow-up of patients with AIDS treated with parenteral cidofovir for cytomegalovirus retinitis: the HPMPC Peripheral Cytomegalovirus Retinitis Trial. The Studies of Ocular Complications of AIDS Research Group in collaboration with the AIDS Clin
Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Male; Morbidity; Organophosphonates; Organophosphorus Compounds; Time Factors; Treatment Outcome; Vision, Ocular | 2000 |
The ganciclovir implant plus oral ganciclovir versus parenteral cidofovir for the treatment of cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome: The Ganciclovir Cidofovir Cytomegalovirus Retinitis Trial.
Topics: Administration, Oral; Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Disease Progression; Double-Blind Method; Drug Evaluation; Drug Implants; Female; Ganciclovir; Humans; Infusions, Parenteral; Kidney; Male; Organophosphonates; Organophosphorus Compounds; Survival Rate; Treatment Outcome; Uveitis; Visual Acuity; Vitreous Hemorrhage | 2001 |
SOCA research group stops enrollment. Studies of the Ocular Complications of AIDS.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Humans; Infusions, Intravenous; Kidney; Organophosphonates; Organophosphorus Compounds | 1996 |
Update on treatment of CMV retinitis.
Topics: Administration, Oral; AIDS-Related Opportunistic Infections; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Drug Implants; Eye; Ganciclovir; Humans; Infusions, Intravenous; Organophosphonates; Organophosphorus Compounds; Randomized Controlled Trials as Topic | 1995 |
78 other study(ies) available for organophosphonates and Cytomegaloviral Retinitis
Article | Year |
---|---|
Case report: persistent cytomegalovirus (CMV) infection after haploidentical hematopoietic stem cell transplantation using in vivo alemtuzumab: emergence of resistant CMV due to mutations in the UL97 and UL54 genes.
Topics: Alemtuzumab; Anemia, Refractory, with Excess of Blasts; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antiviral Agents; Base Sequence; Cidofovir; Cytomegalovirus; Cytomegalovirus Retinitis; Cytosine; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Foscarnet; Ganciclovir; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Sequence Data; Organophosphonates; Phosphotransferases (Alcohol Group Acceptor); Point Mutation; Viral Proteins; Virus Activation | 2008 |
Intraocular pharmacokinetics of a crystalline lipid prodrug, octadecyloxyethyl-cyclic-cidofovir, for cytomegalovirus retinitis.
Topics: Animals; Antiviral Agents; Autoradiography; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Eye; Intravitreal Injections; Organophosphonates; Prodrugs; Rabbits | 2011 |
Drug-induced uveitis in aids patients: two case reports.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Female; Humans; Organophosphonates; Rifabutin; Uveitis | 2011 |
Intraocular safety and pharmacokinetics of hexadecyloxypropyl-cidofovir (HDP-CDV) as a long-lasting intravitreal antiviral drug.
Topics: Animals; Chromatography, High Pressure Liquid; Ciliary Body; Cytomegalovirus Retinitis; Cytosine; Delayed-Action Preparations; Disease Models, Animal; Dose-Response Relationship, Drug; Follow-Up Studies; Hydrolysis; Intravitreal Injections; Organophosphonates; Rabbits; Retina; Vitreous Body | 2011 |
Ganciclovir-resistant cytomegalovirus (CMV) retinitis in a patient with wild-type CMV in her plasma.
Topics: Adult; Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Retinitis; Cytosine; DNA, Viral; Drug Resistance, Viral; Eye; Female; Foscarnet; Ganciclovir; Humans; Organophosphonates; Plasma; Sequence Analysis, DNA | 2012 |
Transporter-targeted lipid prodrugs of cyclic cidofovir: a potential approach for the treatment of cytomegalovirus retinitis.
Topics: Animals; Antiviral Agents; Biological Transport; Biotinylation; Biotransformation; Cell Line; Cell Survival; Chemistry, Pharmaceutical; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Dogs; Eye; Lipid Metabolism; Lipids; Male; Octanols; Organophosphonates; Prodrugs; Rabbits; Solubility; Symporters; Technology, Pharmaceutical; Water | 2012 |
Case report of cytomegalovirus retinitis in an HIV-positive patient with a CD4-count nadir of 254 cells per μl.
Topics: Adenine; Administration, Oral; Adult; Alkynes; Anti-HIV Agents; Aqueous Humor; Benzoxazines; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Cyclopropanes; Cytomegalovirus; Cytomegalovirus Retinitis; Deoxycytidine; Drug Therapy, Combination; Emtricitabine; HIV Infections; Humans; Male; Organophosphonates; Polymerase Chain Reaction; Tenofovir; Visual Acuity | 2012 |
Hypotony after intravenous cidofovir therapy for the treatment of cytomegalovirus retinitis.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Atrophy; Child; Cidofovir; Ciliary Body; Cytomegalovirus Retinitis; Cytosine; Humans; Infusions, Intravenous; Intraocular Pressure; Male; Ocular Hypotension; Organophosphonates; Organophosphorus Compounds; Ultrasonography | 2002 |
HPMPC therapy of MCMV-induced retinal disease in the SCID mouse measured by electroretinography, a non-invasive technique.
Topics: Animals; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Disease Models, Animal; Electroretinography; Eye Infections, Viral; Female; Herpesviridae Infections; Humans; Mice; Mice, SCID; Muromegalovirus; Organophosphonates; Organophosphorus Compounds; Retina; Treatment Outcome; Virus Replication | 2003 |
[Bilateral uveitis with definitive hypotony caused by systemic cidofovir].
Topics: AIDS-Related Opportunistic Infections; Cidofovir; Ciliary Body; Cytomegalovirus Retinitis; Cytosine; Foscarnet; Humans; Injections, Intravenous; Male; Middle Aged; Necrosis; Ocular Hypotension; Organophosphonates; Organophosphorus Compounds; Uveitis, Anterior | 2003 |
Effect of anti-cytomegalovirus therapy on the incidence of immune recovery uveitis in AIDS patients with healed cytomegalovirus retinitis.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiretroviral Therapy, Highly Active; Antiviral Agents; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Epiretinal Membrane; Eye Diseases; Female; Humans; Incidence; Macular Edema; Male; Organophosphonates; Organophosphorus Compounds; Risk Factors; Uveitis; Vitreous Body | 2003 |
Efficacy of ganciclovir and cidofovir against human cytomegalovirus replication in SCID mice implanted with human retinal tissue.
Topics: Animals; Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Retinitis; Cytosine; Disease Models, Animal; Ganciclovir; Humans; Mice; Mice, SCID; Organophosphonates; Organophosphorus Compounds; Transplantation, Heterologous; Virus Replication | 2004 |
Perianal ulcer in a patient with AIDS.
Topics: AIDS-Related Opportunistic Infections; Anti-HIV Agents; Cidofovir; Cytomegalovirus Infections; Cytomegalovirus Retinitis; Cytosine; Diagnosis, Differential; Fatal Outcome; Humans; Male; Middle Aged; Organophosphonates; Organophosphorus Compounds; Perineum; Skin Ulcer | 2004 |
Tubular cell apoptosis and cidofovir-induced acute renal failure.
Topics: Acute Kidney Injury; Adult; Annexin A5; Antiviral Agents; Apoptosis; Caspase 3; Caspases; Cells, Cultured; Cidofovir; Cytomegalovirus Retinitis; Cytosine; HIV Infections; Humans; Kidney Tubules, Proximal; Male; Organophosphonates | 2005 |
Intraocular properties of hexadecyloxypropyl-cyclic-cidofovir in Guinea pigs.
Topics: Animals; Antiviral Agents; Ciliary Body; Cytomegalovirus Retinitis; Cytosine; Delayed-Action Preparations; Electroretinography; Guinea Pigs; Injections; Intraocular Pressure; Organophosphonates; Retina; Vitreous Body | 2005 |
Risk of immune recovery uveitis in patients with AIDS and cytomegalovirus retinitis.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Cidofovir; Cross-Sectional Studies; Cytomegalovirus Retinitis; Cytosine; Female; Humans; Injections; Male; Organophosphonates; Prevalence; Risk Factors; Uveitis, Posterior; Visual Acuity; Vitreous Body | 2006 |
From the Food and Drug Administration.
Topics: Advertising; Antiviral Agents; Cidofovir; Commerce; Consumer Advocacy; Cytomegalovirus Retinitis; Cytosine; Drug Industry; Drugs, Investigational; Humans; Nicotiana; Organophosphonates; Organophosphorus Compounds; Patient Education as Topic; Pharmacoepidemiology; Plants, Toxic; United States; United States Food and Drug Administration | 1995 |
AIDS therapy. New hope against blindness.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Blindness; Cidofovir; Clinical Trials as Topic; Cytomegalovirus Retinitis; Cytosine; Drug Implants; Ganciclovir; Humans; Organophosphonates; Organophosphorus Compounds; RNA, Antisense | 1995 |
Distribution and metabolism of intravitreal cidofovir and cyclic HPMPC in rabbits.
Topics: AIDS-Related Opportunistic Infections; Animals; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Eye; Half-Life; Humans; Injections; Kidney; Male; Organophosphonates; Organophosphorus Compounds; Rabbits; Retina; Tissue Distribution; Vitreous Body | 1996 |
Intravitreal cidofovir for the maintenance treatment of cytomegalovirus retinitis.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Disease Progression; Female; Follow-Up Studies; Humans; Injections; Male; Organophosphonates; Organophosphorus Compounds; Prospective Studies; Retinal Detachment; Safety; Survival Rate; Vitreous Body | 1996 |
New developments in the treatment of CMV retinitis.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Foscarnet; Ganciclovir; Humans; Injections; Injections, Intravenous; Organophosphonates; Organophosphorus Compounds; Vitreous Body | 1996 |
Current and experimental therapeutic options for cytomegalovirus disease.
Topics: Administration, Oral; Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytomegalovirus Retinitis; Cytosine; Delayed-Action Preparations; Foscarnet; Ganciclovir; Guanine; Humans; Injections, Intravenous; Organophosphonates; Organophosphorus Compounds | 1996 |
Cidofovir for AIDS-related retinitis.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Disease Progression; Humans; Organophosphonates; Organophosphorus Compounds; Treatment Outcome | 1996 |
More new drugs for HIV and associated infections.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Anti-Bacterial Agents; Antiviral Agents; Cidofovir; Clinical Trials as Topic; Cytomegalovirus Retinitis; Cytosine; HIV Infections; Humans; Isoquinolines; Nelfinavir; Nevirapine; Organophosphonates; Organophosphorus Compounds; Protease Inhibitors; Pyridines; Ritonavir; Sulfonic Acids | 1997 |
Low-dose intravitreal cidofovir (HPMPC) therapy of cytomegalovirus retinitis in patients with acquired immune deficiency syndrome.
Topics: Adolescent; Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Disease Progression; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Fundus Oculi; Humans; Injections; Male; Middle Aged; Organophosphonates; Organophosphorus Compounds; Retrospective Studies; Treatment Outcome; Vitreous Body | 1997 |
Successful treatment of cytomegalovirus encephalitis in an AIDS patient using cidofovir.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Infections; Cytomegalovirus Retinitis; Cytosine; Encephalitis, Viral; Humans; Magnetic Resonance Imaging; Male; Organophosphonates; Organophosphorus Compounds; Treatment Outcome | 1997 |
Fanconi syndrome associated with cidofovir therapy.
Topics: Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Fanconi Syndrome; HIV Seropositivity; Humans; Male; Middle Aged; Organophosphonates; Organophosphorus Compounds | 1997 |
Nephrogenic diabetes insipidus in a patient taking cidofovir.
Topics: Adult; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Diabetes Insipidus, Nephrogenic; Humans; Male; Organophosphonates; Organophosphorus Compounds | 1997 |
Cidofovir for cytomegalovirus retinitis.
Topics: Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Ethics, Medical; Humans; Organophosphonates; Organophosphorus Compounds; Research Design | 1997 |
Recurrent iritis after intravenous administration of cidofovir.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; CD4 Lymphocyte Count; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Humans; Iritis; Male; Organophosphonates; Organophosphorus Compounds; Recurrence | 1997 |
Ophthalmic complications of HIV/AIDS.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Humans; Organophosphonates; Organophosphorus Compounds | 1997 |
Adverse events and autopsy findings after intravitreous cidofovir (HPMPC) therapy in patients with acquired immune deficiency syndrome (AIDS).
Topics: Adult; AIDS-Related Opportunistic Infections; Anterior Eye Segment; Antiviral Agents; Autopsy; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Female; Follow-Up Studies; Fundus Oculi; Humans; Injections; Iritis; Male; Middle Aged; Ocular Hypotension; Organophosphonates; Organophosphorus Compounds; Pigment Epithelium of Eye; Prospective Studies; Vitreous Body | 1997 |
[More successful therapy of CMV retinitis in AIDS patients].
Topics: AIDS-Related Opportunistic Infections; Anti-HIV Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; HIV-1; Humans; Organophosphonates; Organophosphorus Compounds | 1997 |
Clinical failure of CMV retinitis with intravitreal cidofovir is associated with antiviral resistance.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Retinitis; Cytosine; DNA, Viral; Drug Resistance, Microbial; Ganciclovir; Humans; Injections; Male; Middle Aged; Organophosphonates; Organophosphorus Compounds; Polymerase Chain Reaction; Treatment Failure; Vitreous Body | 1998 |
New issues in the management of cytomegalovirus retinitis in AIDS patients.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Drug Implants; Foscarnet; Ganciclovir; Humans; Organophosphonates; Organophosphorus Compounds | 1998 |
Anterior uveitis and hypotony after intravenous cidofovir for the treatment of cytomegalovirus retinitis.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; CD4 Lymphocyte Count; Cidofovir; Cohort Studies; Cytomegalovirus Retinitis; Cytosine; Female; Humans; Incidence; Injections, Intravenous; Intraocular Pressure; Male; Middle Aged; Ocular Hypotension; Organophosphonates; Organophosphorus Compounds; Retrospective Studies; Risk Factors; Treatment Outcome; Uveitis, Anterior | 1998 |
Lack of efficacy of cidofovir in treating AIDS-related cytomegalovirus retinitis after long-term treatment with ganciclovir.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Foscarnet; Ganciclovir; Humans; Male; Organophosphonates; Organophosphorus Compounds; Recurrence | 1998 |
Lack of reactivation of cytomegalovirus (CMV) retinitis after stopping CMV maintenance therapy in AIDS patients with sustained elevations in CD4 T cells in response to highly active antiretroviral therapy.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antiviral Agents; CD4 Lymphocyte Count; Cidofovir; Cytomegalovirus; Cytomegalovirus Retinitis; Cytosine; Drug Therapy, Combination; Female; HIV Protease Inhibitors; HIV-1; Humans; Male; Organophosphonates; Organophosphorus Compounds; Recurrence; Virus Activation; Virus Replication | 1998 |
[Fabrication of cidofovir ampules for intravitreal injections for cytomegalovirus retinitis].
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Chemistry, Pharmaceutical; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Drug Compounding; Drug Packaging; Humans; Injections; Male; Middle Aged; Organophosphonates; Organophosphorus Compounds; Vitreous Body | 1998 |
Abatement of cutaneous Kaposi's sarcoma associated with cidofovir treatment.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Herpesvirus 8, Human; Humans; Male; Organophosphonates; Organophosphorus Compounds; Sarcoma, Kaposi; Skin Neoplasms | 1998 |
Incidence of foscarnet resistance and cidofovir resistance in patients treated for cytomegalovirus retinitis. The Cytomegalovirus Retinitis and Viral Resistance Study Group.
Topics: Adult; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Drug Resistance; Female; Foscarnet; Humans; Male; Organophosphonates; Organophosphorus Compounds; Prospective Studies | 1998 |
Cytomegalovirus retinitis and viral resistance: 3. Culture results. CMV Retinitis and Viral Resistance Study Group.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Baltimore; Blood; Cidofovir; Cytomegalovirus; Cytomegalovirus Retinitis; Cytosine; Drug Resistance, Microbial; Female; Follow-Up Studies; Foscarnet; Ganciclovir; Humans; Male; Organophosphonates; Organophosphorus Compounds; Prognosis; Prospective Studies; Survival Rate; Urine; Viremia | 1998 |
[Intravitreal injection of cidofovir in cytomegalovirus retinitis].
Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Female; Humans; Injections; Male; Middle Aged; Organophosphonates; Organophosphorus Compounds; Vitreous Body | 1998 |
[Manufacturing of cidofovir for intravitreal injections in cytomegalovirus retinitis].
Topics: Antiviral Agents; Chemistry, Pharmaceutical; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Drug Industry; Drug Packaging; Europe; Humans; Injections; Organophosphonates; Organophosphorus Compounds; United States; Vitreous Body | 1998 |
In vitro antiviral susceptibilities of isolates from cytomegalovirus retinitis patients receiving first- or second-line cidofovir therapy: relationship to clinical outcome.
Topics: Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Retinitis; Cytosine; Drug Resistance, Microbial; Foscarnet; Ganciclovir; Genotype; Humans; Microbial Sensitivity Tests; Organophosphonates; Organophosphorus Compounds; Recurrence | 1998 |
Cytomegalovirus iritis.
Topics: Adult; AIDS-Related Opportunistic Infections; Antibodies, Viral; Antigens, Viral; Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytomegalovirus Retinitis; Cytosine; Fatal Outcome; Humans; Immunohistochemistry; Iris; Iritis; Male; Organophosphonates; Organophosphorus Compounds | 1998 |
Discontinuing anticytomegalovirus therapy in patients with immune reconstitution after combination antiretroviral therapy.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Drug Implants; Drug Therapy, Combination; Female; Ganciclovir; HIV-1; Humans; Male; Middle Aged; Organophosphonates; Organophosphorus Compounds; Viral Load | 1998 |
Incidence of immune recovery vitritis in cytomegalovirus retinitis patients following institution of successful highly active antiretroviral therapy.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; California; Cidofovir; Cohort Studies; Cytomegalovirus Retinitis; Cytosine; Eye Diseases; Follow-Up Studies; Humans; Incidence; Inflammation; Organophosphonates; Organophosphorus Compounds; Prospective Studies; Retrospective Studies; Syndrome; Time Factors; Visual Acuity; Vitreous Body | 1999 |
Intravenous cidofovir-induced iritis.
Topics: Adult; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Female; Humans; Injections, Intravenous; Iritis; Male; Middle Aged; Organophosphonates; Organophosphorus Compounds | 1999 |
Vitrectomy and silicone oil tamponade for cidofovir-associated hypotony with ciliary body detachment.
Topics: AIDS-Related Opportunistic Infections; Cidofovir; Ciliary Body; Cytomegalovirus Retinitis; Cytosine; Eye Diseases; Humans; Lens Implantation, Intraocular; Lens, Crystalline; Male; Middle Aged; Ocular Hypotension; Organophosphonates; Organophosphorus Compounds; Silicone Oils; Ultrasonography; Vitrectomy | 1999 |
Iritis associated with intravenous cidofovir.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Humans; Infusions, Intravenous; Iritis; Male; Organophosphonates; Organophosphorus Compounds | 1999 |
Surgical repair of cytomegalovirus-related retinal detachment without silicone oil in patients with AIDS.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; CD4 Lymphocyte Count; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Female; Fluorocarbons; Follow-Up Studies; HIV-1; Humans; Laser Coagulation; Male; Organophosphonates; Organophosphorus Compounds; Retinal Detachment; Scleral Buckling; Silicone Oils; Sulfur Hexafluoride; Visual Acuity; Vitrectomy | 1999 |
Anterior uveitis associated with intravenous cidofovir use in patients with cytomegalovirus retinitis.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Case-Control Studies; CD4 Lymphocyte Count; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Female; Humans; Male; Middle Aged; Organophosphonates; Organophosphorus Compounds; Retrospective Studies; Risk Factors; Uveitis, Anterior | 1999 |
Cystoid macular edema following immune recovery and treatment with cidofovir for cytomegalovirus retinitis.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; CD4 Lymphocyte Count; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Fluorescein Angiography; Follow-Up Studies; Fundus Oculi; Humans; Injections, Intravenous; Macular Edema; Organophosphonates; Organophosphorus Compounds; Retrospective Studies; Vitreous Body | 1999 |
Intravenous cidofovir for compassionate use in AIDS patients with cytomegalovirus retinitis. Spanish Cidofovir Study Group.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antiviral Agents; Cidofovir; Cohort Studies; Cytomegalovirus Retinitis; Cytosine; Drug Therapy, Combination; Female; Humans; Male; Organophosphonates; Organophosphorus Compounds; Treatment Outcome | 2000 |
Ocular complications of intravenous cidofovir for cytomegalovirus retinitis in patients with AIDS.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; CD4 Lymphocyte Count; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Female; Humans; Male; Middle Aged; Ocular Hypotension; Organophosphonates; Organophosphorus Compounds; Retrospective Studies; Uveitis, Anterior | 1999 |
Lack of reactivation of cytomegalovirus retinitis in an AIDS patient, during and after stopping long-term cidofovir treatment: case report.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Retinitis; Cytosine; Drug Administration Schedule; Humans; Male; Organophosphonates; Organophosphorus Compounds; Virus Activation | 2000 |
CMV complications in common variable immunodeficiency.
Topics: Adult; Antiviral Agents; Azathioprine; B-Lymphocytes; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cidofovir; Colitis; Common Variable Immunodeficiency; Cytomegalovirus Infections; Cytomegalovirus Retinitis; Cytosine; Cytotoxicity Tests, Immunologic; Encephalitis, Viral; Female; Foscarnet; Humans; K562 Cells; Killer Cells, Natural; Myelitis; Organophosphonates; Organophosphorus Compounds; Phosphoproteins; Viral Matrix Proteins | 2000 |
[Stopping secondary prevention in AIDS patients with inactive CMV retinitis treated with HAART (highly active antiretroviral therapy)].
Topics: AIDS-Related Opportunistic Infections; Antiretroviral Therapy, Highly Active; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Follow-Up Studies; Foscarnet; Ganciclovir; Humans; Organophosphonates; Organophosphorus Compounds | 2000 |
A deletion mutation in region V of the cytomegalovirus DNA polymerase sequence confers multidrug resistance.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Retinitis; Cytosine; DNA-Directed DNA Polymerase; Drug Resistance, Microbial; Drug Resistance, Multiple; Foscarnet; Ganciclovir; Gene Deletion; Humans; Mutation; Organophosphonates; Organophosphorus Compounds; Phosphotransferases; Transfection | 2000 |
[Severe alopecia caused by cidofovir]].
Topics: Adult; AIDS-Related Opportunistic Infections; Alopecia; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Humans; Male; Organophosphonates; Organophosphorus Compounds | 2000 |
Virological, clinical, and ophthalmologic features of cytomegalovirus retinitis after hematopoietic stem cell transplantation.
Topics: Adult; Antiviral Agents; Chronic Disease; Cidofovir; Cytomegalovirus; Cytomegalovirus Retinitis; Cytosine; Female; Foscarnet; Ganciclovir; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Male; Middle Aged; Organophosphonates; Organophosphorus Compounds; Postoperative Complications; Risk Factors; Treatment Outcome; Virus Activation | 2001 |
FDA grants marketing clearance of Vistide for the treatment of CMV retinitis.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Drug Approval; Humans; Organophosphonates; Organophosphorus Compounds; United States; United States Food and Drug Administration | 1996 |
CMV retinitis: a clinical management update.
Topics: AIDS-Related Opportunistic Infections; Algorithms; Antiviral Agents; Cidofovir; Clinical Protocols; Clinical Trials as Topic; Cytomegalovirus; Cytomegalovirus Retinitis; Cytosine; Drug Implants; Drug Resistance, Microbial; Drug Therapy, Combination; Foscarnet; Ganciclovir; Humans; Injections; Organophosphonates; Organophosphorus Compounds; Patient Participation; Vitreous Body | 1996 |
Pharmacia and Upjohn and Gilead sciences receive European recommendation for cidofovir.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Drug Administration Schedule; Drug Industry; Europe; Humans; Infusions, Intravenous; Organophosphonates; Organophosphorus Compounds; Product Surveillance, Postmarketing | 1997 |
Second National Retrovirus conference: a further report.
Topics: Acetamides; Acetophenones; Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; Cause of Death; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Female; Ganciclovir; Humans; Male; Organophosphonates; Organophosphorus Compounds; Paclitaxel; Reverse Transcriptase Inhibitors; Sarcoma, Kaposi; Tuberculosis | 1995 |
Advances in the treatment of CMV.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Clinical Trials, Phase I as Topic; Clinical Trials, Phase III as Topic; Cytomegalovirus Retinitis; Cytosine; Drug Implants; Drug Therapy, Combination; Eye; Foscarnet; Ganciclovir; Humans; Organophosphonates; Organophosphorus Compounds; Quality of Life | 1995 |
Cidofovir approved.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Drug Administration Schedule; Humans; Organophosphonates; Organophosphorus Compounds; Quality of Life | 1996 |
Anti-HIV agents at ICAAC.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; CD4 Lymphocyte Count; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Isoquinolines; Kidney; Mutation; Nelfinavir; Organophosphonates; Organophosphorus Compounds; Reverse Transcriptase Inhibitors; Ritonavir; Saquinavir; Sulfonic Acids; Treatment Failure; Viral Load | 1996 |
Update on cidofovir for CMV retinitis.
Topics: Administration, Topical; Antiviral Agents; CD4 Lymphocyte Count; Cidofovir; Clinical Trials as Topic; Cytomegalovirus Retinitis; Cytosine; Drug Implants; Drug Resistance, Microbial; Humans; Microbial Sensitivity Tests; Organophosphonates; Organophosphorus Compounds | 1997 |
Fomivirsen.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Clinical Trials as Topic; Cytomegalovirus Retinitis; Cytosine; Disease Progression; Foscarnet; Ganciclovir; Health Services Accessibility; Humans; Organophosphonates; Organophosphorus Compounds; Thionucleotides | 1998 |
Cidofovir.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Drug Interactions; Drug Therapy, Combination; Humans; Injections, Intravenous; Organophosphonates; Organophosphorus Compounds; Probenecid; Uricosuric Agents | 1998 |
A rocky road for nucleotide analogs.
Topics: Adenine; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Clinical Trials as Topic; Cytomegalovirus Retinitis; Cytosine; HIV Infections; Humans; Organophosphonates; Organophosphorus Compounds | 1998 |
[Anterior uveitis and cidofovir].
Topics: Adult; AIDS-Related Opportunistic Infections; CD4 Lymphocyte Count; Cidofovir; Creatinine; Cytomegalovirus Retinitis; Cytosine; Female; Humans; Male; Metabolic Clearance Rate; Middle Aged; Ophthalmoscopy; Organophosphonates; Organophosphorus Compounds; Recurrence; Retrospective Studies; Time Factors; Tissue Distribution; Uveitis, Anterior | 2001 |
Cytomegalovirus ventriculoencephalitis in a bone marrow transplant recipient receiving antiviral maintenance: clinical and molecular evidence of drug resistance.
Topics: Antiviral Agents; Bone Marrow Transplantation; Cerebral Ventricles; Child; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Drug Combinations; Drug Resistance, Viral; Encephalitis, Viral; Female; Foscarnet; Ganciclovir; Humans; Immunocompromised Host; Organophosphonates; Organophosphorus Compounds | 2001 |
Treatment of severe ocular hypotony in AIDS patients with cytomegalovirus retinitis and cidofovir-associated uveitis.
Topics: AIDS-Related Opportunistic Infections; Animals; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Deoxyepinephrine; Dexamethasone; Dopamine Agonists; Drug Therapy, Combination; Glucocorticoids; Humans; Intraocular Pressure; Ocular Hypotension; Ophthalmic Solutions; Organophosphonates; Organophosphorus Compounds; Uveitis, Anterior | 2001 |
Treatment of severe ocular hypotony in AIDS patients with cytomegalovirus retinitis and cidofovir-associated uveitis.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiretroviral Therapy, Highly Active; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Deoxyepinephrine; Dexamethasone; Dopamine Agonists; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Intraocular Pressure; Ocular Hypotension; Ophthalmic Solutions; Organophosphonates; Organophosphorus Compounds; Uveitis, Anterior | 2001 |
A case of flare syndrome.
Topics: Acute Disease; Adult; AIDS-Related Opportunistic Infections; Antiretroviral Therapy, Highly Active; Antiviral Agents; CD4 Lymphocyte Count; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Drug Therapy, Combination; Ganciclovir; HIV Infections; Humans; Indinavir; Lamivudine; Male; Organophosphonates; Organophosphorus Compounds; Zidovudine | 2001 |